Oral Mucosal Absorption of ICI176,334-1
NCT01415791
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
ICI176,334-1
Sponsor
AstraZeneca